Correlation Between Novartis and AbbVie

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Novartis and AbbVie at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novartis and AbbVie into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novartis AG ADR and AbbVie Inc, you can compare the effects of market volatilities on Novartis and AbbVie and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novartis with a short position of AbbVie. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novartis and AbbVie.

Diversification Opportunities for Novartis and AbbVie

-0.28
  Correlation Coefficient

Very good diversification

The 3 months correlation between Novartis and AbbVie is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Novartis AG ADR and AbbVie Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AbbVie Inc and Novartis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novartis AG ADR are associated (or correlated) with AbbVie. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AbbVie Inc has no effect on the direction of Novartis i.e., Novartis and AbbVie go up and down completely randomly.

Pair Corralation between Novartis and AbbVie

Considering the 90-day investment horizon Novartis AG ADR is expected to under-perform the AbbVie. But the stock apears to be less risky and, when comparing its historical volatility, Novartis AG ADR is 1.18 times less risky than AbbVie. The stock trades about -0.2 of its potential returns per unit of risk. The AbbVie Inc is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  17,899  in AbbVie Inc on December 29, 2023 and sell it today you would earn a total of  209.50  from holding AbbVie Inc or generate 1.17% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.65%
ValuesDaily Returns

Novartis AG ADR  vs.  AbbVie Inc

 Performance 
       Timeline  
Novartis AG ADR 

Risk-Adjusted Performance

0 of 100

 
Low
 
High
Very Weak
Over the last 90 days Novartis AG ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Novartis is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
AbbVie Inc 

Risk-Adjusted Performance

22 of 100

 
Low
 
High
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in AbbVie Inc are ranked lower than 22 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting fundamental drivers, AbbVie showed solid returns over the last few months and may actually be approaching a breakup point.

Novartis and AbbVie Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Novartis and AbbVie

The main advantage of trading using opposite Novartis and AbbVie positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novartis position performs unexpectedly, AbbVie can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AbbVie will offset losses from the drop in AbbVie's long position.
The idea behind Novartis AG ADR and AbbVie Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Fundamental Analysis
View fundamental data based on most recent published financial statements
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Stocks Directory
Find actively traded stocks across global markets
Commodity Directory
Find actively traded commodities issued by global exchanges
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments